Ion Beam Applications SA - Asset Resilience Ratio
Ion Beam Applications SA (IBAB) has an Asset Resilience Ratio of 0.03% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check IBAB strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Ion Beam Applications SA's Asset Resilience Ratio has changed over time. See IBAB equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Ion Beam Applications SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IBAB stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €172.00K | 0.03% |
| Total Liquid Assets | €172.00K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Ion Beam Applications SA maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ion Beam Applications SA Industry Peers by Asset Resilience Ratio
Compare Ion Beam Applications SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
Annual Asset Resilience Ratio for Ion Beam Applications SA (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Ion Beam Applications SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.07% | €416.00K ≈ $486.35K |
€616.10 Million ≈ $720.29 Million |
+0.02pp |
| 2023-12-31 | 0.05% | €309.00K ≈ $361.25K |
€597.53 Million ≈ $698.57 Million |
+0.03pp |
| 2022-12-31 | 0.03% | €160.00K ≈ $187.06K |
€623.90 Million ≈ $729.40 Million |
+0.01pp |
| 2021-12-31 | 0.02% | €82.00K ≈ $95.87K |
€546.05 Million ≈ $638.39 Million |
-0.29pp |
| 2020-12-31 | 0.31% | €1.58 Million ≈ $1.84 Million |
€511.00 Million ≈ $597.41 Million |
+0.23pp |
| 2019-12-31 | 0.08% | €320.00K ≈ $374.11K |
€425.11 Million ≈ $497.00 Million |
+0.05pp |
| 2018-12-31 | 0.02% | €95.00K ≈ $111.06K |
€407.24 Million ≈ $476.11 Million |
-0.89pp |
| 2017-12-31 | 0.92% | €3.05 Million ≈ $3.56 Million |
€332.52 Million ≈ $388.75 Million |
+0.56pp |
| 2016-12-31 | 0.35% | €1.35 Million ≈ $1.57 Million |
€380.62 Million ≈ $444.98 Million |
+0.25pp |
| 2015-12-31 | 0.11% | €422.00K ≈ $493.36K |
€395.35 Million ≈ $462.21 Million |
-0.02pp |
| 2014-12-31 | 0.12% | €381.00K ≈ $445.43K |
€307.06 Million ≈ $358.98 Million |
-0.01pp |
| 2013-12-31 | 0.13% | €367.00K ≈ $429.06K |
€281.75 Million ≈ $329.40 Million |
+0.10pp |
| 2012-12-31 | 0.03% | €121.00K ≈ $141.46K |
€386.20 Million ≈ $451.51 Million |
-0.17pp |
| 2011-12-31 | 0.21% | €1.02 Million ≈ $1.20 Million |
€498.01 Million ≈ $582.23 Million |
-0.08pp |
| 2010-12-31 | 0.29% | €1.53 Million ≈ $1.79 Million |
€528.21 Million ≈ $617.53 Million |
-0.25pp |
| 2009-12-31 | 0.54% | €2.59 Million ≈ $3.03 Million |
€479.64 Million ≈ $560.75 Million |
+0.09pp |
| 2008-12-31 | 0.45% | €2.27 Million ≈ $2.66 Million |
€509.52 Million ≈ $595.68 Million |
-0.13pp |
| 2007-12-31 | 0.57% | €1.86 Million ≈ $2.17 Million |
€324.44 Million ≈ $379.30 Million |
+0.47pp |
| 2006-12-31 | 0.11% | €284.00K ≈ $332.03K |
€266.87 Million ≈ $312.00 Million |
-13.04pp |
| 2005-12-31 | 13.15% | €26.66 Million ≈ $31.17 Million |
€202.75 Million ≈ $237.04 Million |
-15.79pp |
| 2004-12-31 | 28.94% | €99.90 Million ≈ $116.79 Million |
€345.22 Million ≈ $403.60 Million |
+28.78pp |
| 2003-12-31 | 0.16% | €818.00K ≈ $956.33K |
€500.56 Million ≈ $585.21 Million |
-5.56pp |
| 2002-12-31 | 5.72% | €39.47 Million ≈ $46.15 Million |
€690.15 Million ≈ $806.86 Million |
+1.01pp |
| 2001-12-31 | 4.71% | €36.03 Million ≈ $42.12 Million |
€764.48 Million ≈ $893.75 Million |
-9.33pp |
| 2000-12-31 | 14.04% | €105.72 Million ≈ $123.60 Million |
€753.05 Million ≈ $880.39 Million |
-- |
About Ion Beam Applications SA
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. Thi… Read more